drug
vopimetostat
Phase 2updated 3mo agoby $TNGX Tango Therapeutics, Inc.
Phase 2community read0 votes
indications
indications
NSCLC
all catalysts(0)
nothing on the calendar yet
News(3)
- Tango data add to growing momentum for pancreatic cancer drugsA combination involving Tango’s experimental therapy appeared to boost response rates in a small clinical trial well beyond what would be expected, sparking a share surge.biopharma_dive · 2mo ago
- STAT+: Pharmalittle: We’re reading about Lilly and Pfizer obesity drug data, Roche and J&J deals, and moreLilly disclosed new data that provide more details on the safety and tolerability of its next-generation obesity drug retatrutidestat · 2mo ago
- STAT+: Combination of pancreatic cancer drugs from Tango, Revolution leads to high response rateA combination of pancreatic cancer drugs from Tango Therapeutics and Revolution Medicines led to a strong response rate in an early-stage trial.stat · 2mo ago
Data sources
last refreshed 58m ago
Found something off?
comments(0)
5-min edit window · permanent after that